Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

29.3K
Overview
29.3K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

812
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
812
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.1K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

713
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
713
Cross-reactivity00:42

Cross-reactivity

31.8K
Overview
31.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metaceramic enables ultrahigh-temperature record rectification and programmable 3D thermal control.

Science advances·2026
Same author

Time-temperature-transformation-layering diagrams: a design tool for lightweight multi-layered, single-material polymeric structures.

Materials horizons·2026
Same author

3D-Printed Polylactide-Based Implants: Influence of Processing, Radiation Sterilization and In Vivo Bioresorption on Structural and Physicochemical Material Characteristics.

Polymers·2026
Same author

Environmental pollutant BDE-47 alters glycan and microRNA signatures of macrophage-derived extracellular vesicles and modulates senescence signaling.

Cell communication and signaling : CCS·2026
Same author

Exploring the Impact of Polychlorinated Biphenyls (PCBs) on the Development of MASLD: A Comprehensive Review.

Cells·2026
Same author

A novel spliceosomopathy caused by de novo SF3B3 variants.

Genome medicine·2026
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: Oct 23, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.5K

Nanoparticles in allergen immunotherapy.

Alessandra Longo1, Valeria Longo, Paolo Colombo

  • 1Institute for Biomedical Research and Innovation, National Research Council of Italy (IRIB-CNR), Palermo, Italy.

Current Opinion in Allergy and Clinical Immunology
|August 22, 2021
PubMed
Summary
This summary is machine-generated.

Nanoparticle-based allergen immunotherapy offers a novel approach to treating allergic diseases by modulating the immune system. This review examines the safety and efficacy of using nanomaterials as adjuvants in allergen immunotherapy.

More Related Videos

Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles
11:26

Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles

Published on: June 8, 2012

20.0K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.7K

Related Experiment Videos

Last Updated: Oct 23, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.5K
Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles
11:26

Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles

Published on: June 8, 2012

20.0K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.7K

Area of Science:

  • Immunology
  • Nanotechnology
  • Allergy Research

Background:

  • Allergen immunotherapy is the only causal treatment for allergic diseases, modulating immune responses.
  • Adjuvants are used with allergens to enhance immune tolerance and prolong release.
  • Nanotechnology advancements have introduced safer nanoscale materials for pharmaceutical adjuvants.

Purpose of the Study:

  • To review the properties of allergen/nanoparticle complexes for immunotherapy.
  • To evaluate the potential of nanomaterials as pharmaceutical adjuvants in allergy treatment.
  • To explore innovative paradigms in allergen immunotherapy using nanotechnology.

Main Methods:

  • Analysis of allergen/nanoparticle properties.
  • In vitro assessment of cytotoxicity and stability.
  • In vivo evaluation of immunogenic reactions in animal models.

Main Results:

  • Nanomaterials offer unique properties for developing safer drug carriers with enhanced stability and immunomodulatory effects.
  • Nanoparticles can act as adjuvants or be formulated with allergens to influence release dynamics.
  • Investigation into cytotoxicity, stability, and immunogenicity of allergen-nanoparticle systems.

Conclusions:

  • Nanoparticle-based allergen immunotherapy presents a promising avenue for treating allergic diseases.
  • Further research is needed to fully understand the safety and efficacy of these novel therapeutic approaches.
  • Nanomaterials hold significant potential for advancing allergen immunotherapy strategies.